Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study-Reference-Cited by-同舟云学术

Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study

Published:2021 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hosoi Hiroki¹,Mushino Toshiki¹,Nakashima Kazutaka²,Kuriyama Kodai³,Tamura Shinobu¹,Murata Shogo¹,Imadome Ken-Ichi⁴,Ohshima Koichi²,Sonoki Takashi¹

Affiliation:

1. Department of Hematology/Oncology, Wakayama Medical University, Japan

2. Department of Pathology, Kurume University School of Medicine, Japan

3. Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Japan

4. Department of Advanced Medicine for Infections, National Center for Child Health and Development, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_6572-20/_pdf

Reference17 articles.

1. 1. Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16: 789-802, 2016.

2. 2. Fox CP, Shannon-Lowe C, Rowe M. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae 2: 8, 2011.

3. 3. Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol 81: 7825-7832, 2007.

4. 4. Braun M, Melchers I, Peter HH, Illges H. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein. Int Immunol 10: 1197-1202, 1998.

5. 5. Castillo JJ, Reagan JL, Bishop KD, Apor E. Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies. Br J Haematol 165: 300-315, 2014.